日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4

开发检测流程,用于发现人类谷胱甘肽过氧化物酶 GPX1 和 GPX4 的新型小分子抑制剂

Dorian M Cheff, Qing Cheng, Hui Guo, Jameson Travers, Carleen Klumpp-Thomas, Min Shen, Elias S J Arnér, Matthew D Hall

The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1

诱导铁死亡的化合物 RSL3 和 ML162 不是 GPX4 的直接抑制剂,而是 TXNRD1 的直接抑制剂

Dorian M Cheff, Chuying Huang, Karoline C Scholzen, Radosveta Gencheva, Michael H Ronzetti, Qing Cheng, Matthew D Hall, Elias S J Arnér

Arsenic exposure and increased C-reactive protein are independently associated with lower erythrocyte glutathione peroxidase activity in Bangladeshi children

砷暴露和 C 反应蛋白升高与孟加拉国儿童红细胞谷胱甘肽过氧化物酶活性降低独立相关

Dorian M Cheff, Helena Skröder, Evana Akhtar, Qing Cheng, Matthew D Hall, Rubhana Raqib, Maria Kippler, Marie Vahter, Elias S J Arnér

Discovery and Optimization of 2 H-1λ2-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer

突变异柠檬酸脱氢酶 1 的 2 H-1λ2-吡啶-2-酮抑制剂的发现和优化用于治疗癌症

Jason M Rohde, Surendra Karavadhi, Rajan Pragani, Li Liu, Yuhong Fang, Weihe Zhang, Andrew McIver, Hongchao Zheng, Qingyang Liu, Mindy I Davis, Daniel J Urban, Tobie D Lee, Dorian M Cheff, Melinda Hollingshead, Mark J Henderson, Natalia J Martinez, Kyle R Brimacombe, Adam Yasgar, Wei Zhao, Carleen K

Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties

具有优化细胞活性和药代动力学特性的吡唑基乳酸脱氢酶抑制剂

Ganesha Rai, Daniel J Urban, Bryan T Mott, Xin Hu, Shyh-Ming Yang, Gloria A Benavides, Michelle S Johnson, Giuseppe L Squadrito, Kyle R Brimacombe, Tobie D Lee, Dorian M Cheff, Hu Zhu, Mark J Henderson, Katherine Pohida, Gary A Sulikowski, David M Dranow, Md Kabir, Pranav Shah, Elias Padilha, Dingyi

Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling

表观遗传靶向治疗的耐药性导致与增强子重塑相关的肿瘤细胞脆弱性

Amanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, Giovanni Roti, Sarvagna Patel, Liying Chen, Samuel Kitara, Amy Conway, Amanda L Robichaud, Björn Stolte, Pratiti Bandopadhayay, Amy Goodale, Sasha Pantel, Yenarae Lee, Dorian M Cheff, Matthew D Hall, Rajarshi Guha, Mindy I Davis, Marie Menard, 

High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2

利用核小体底物进行高通量筛选,鉴定出人类组蛋白赖氨酸甲基转移酶 NSD2 的小分子抑制剂

Nathan P Coussens, Stephen C Kales, Mark J Henderson, Olivia W Lee, Kurumi Y Horiuchi, Yuren Wang, Qing Chen, Ekaterina Kuznetsova, Jianghong Wu, Sirisha Chakka, Dorian M Cheff, Ken Chih-Chien Cheng, Paul Shinn, Kyle R Brimacombe, Min Shen, Anton Simeonov, Madhu Lal-Nag, Haiching Ma, Ajit Jadhav, Ma

Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors

哌嗪-1-硫脲类人类磷酸甘油酸脱氢酶抑制剂的发现与优化

Jason M Rohde, Kyle R Brimacombe, Li Liu, Michael E Pacold, Adam Yasgar, Dorian M Cheff, Tobie D Lee, Ganesha Rai, Bolormaa Baljinnyam, Zhuyin Li, Anton Simeonov, Matthew D Hall, Min Shen, David M Sabatini, Matthew B Boxer

Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays

使用一套临床前发现检测方法评估突变异柠檬酸脱氢酶抑制剂

Daniel J Urban, Natalia J Martinez, Mindy I Davis, Kyle R Brimacombe, Dorian M Cheff, Tobie D Lee, Mark J Henderson, Steven A Titus, Rajan Pragani, Jason M Rohde, Li Liu, Yuhong Fang, Surendra Karavadhi, Pranav Shah, Olivia W Lee, Amy Wang, Andrew McIver, Hongchao Zheng, Xiaodong Wang, Xin Xu, Ajit